Published in Schizophr Res on October 17, 2012
The Puzzle of Processing Speed, Memory, and Executive Function Impairments in Schizophrenia: Fitting the Pieces Together. Biol Psychiatry (2015) 1.46
Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia. JAMA Psychiatry (2016) 0.89
Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study. Mol Psychiatry (2015) 0.83
Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients. Eur Arch Psychiatry Clin Neurosci (2016) 0.78
Response selection impairment in schizophrenia transcends sensory and motor modalities. Schizophr Res (2013) 0.75
Compromised Motor Dexterity Confounds Processing Speed Task Outcomes in Stroke Patients. Front Neurol (2017) 0.75
The Processing-Speed Impairment in Psychosis Is More Than Just Accelerated Aging. Schizophr Bull (2017) 0.75
The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cogn Psychol (2000) 21.06
The processing-speed theory of adult age differences in cognition. Psychol Rev (1996) 15.76
Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry (1994) 11.85
What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry (1996) 11.03
Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34
Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry (2007) 4.44
Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res (1984) 4.28
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
"Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull (1998) 3.67
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry (2010) 3.05
Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull (2007) 2.25
An fMRI study of the Trail Making Test. Neuropsychologia (2005) 2.24
Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology (2010) 2.20
A systematic review and quantitative appraisal of fMRI studies of verbal fluency: role of the left inferior frontal gyrus. Hum Brain Mapp (2006) 1.96
Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. J Int Neuropsychol Soc (2006) 1.77
Is schizophrenia a syndrome of accelerated aging? Schizophr Bull (2007) 1.70
A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry (2003) 1.63
How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophr Bull (2007) 1.53
Processing speed deficits in schizophrenia: reexamining the evidence. Am J Psychiatry (2010) 1.52
A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis. Schizophr Res (2006) 1.49
Adjudicating neurocognitive endophenotypes for schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2007) 1.48
Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am J Psychiatry (2001) 1.43
Age-based structural dynamics between perceptual speed and knowledge in the Berlin Aging Study: direct evidence for ability dedifferentiation in old age. Psychol Aging (2003) 1.41
The cerebral correlates of set-shifting: an fMRI study of the trail making test. Arq Neuropsiquiatr (2003) 1.40
Structural correlates of semantic and phonemic fluency ability in first and second languages. Cereb Cortex (2009) 1.34
Decoding digit symbol: speed, memory, and visual scanning. Assessment (2003) 1.24
Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. Schizophr Bull (2010) 1.21
A meta-analytic review of verbal fluency deficits in schizophrenia relative to other neurocognitive deficits. Cogn Neuropsychiatry (2005) 1.06
Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls. Schizophr Res (2007) 1.04
Activation of the prefrontal cortex during the Trail-Making Test detected with multichannel near-infrared spectroscopy. Psychiatry Clin Neurosci (2007) 1.02
Speed and memory in WAIS-R-NI Digit Symbol performance among healthy older adults. J Int Neuropsychol Soc (2000) 0.96
Differentiating simple versus complex processing speed: influence on new learning and memory performance. J Clin Exp Neuropsychol (2003) 0.92
Memory and motor skill components of the WAIS-III Digit Symbol-Coding subtest. Clin Neuropsychol (2001) 0.92
Factor structures of the neurocognitive assessments and familial analysis in first-episode schizophrenia patients, their relatives and controls. Aust N Z J Psychiatry (2010) 0.91
Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals. Hum Brain Mapp (2009) 0.88
Increase in prefrontal cortex blood flow during the computer version trail making test. Neuropsychobiology (2009) 0.84
Clinical application of standardized cognitive assessment using fMRI. II. Verbal fluency. Behav Neurol (2008) 0.81
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet (2008) 6.24
Prevalence of mental incapacity in medical inpatients and associated risk factors: cross-sectional study. Lancet (2004) 5.33
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry (2006) 4.77
Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med (2010) 4.42
Autism and mental retardation among offspring born after in vitro fertilization. JAMA (2013) 4.28
Mental capacity to make decisions on treatment in people admitted to psychiatric hospitals: cross sectional study. BMJ (2008) 3.99
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull (2009) 3.78
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care (2008) 3.65
Advancing paternal age and autism. Arch Gen Psychiatry (2006) 3.58
Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry (2007) 3.42
Superresolution imaging using single-molecule localization. Annu Rev Phys Chem (2010) 3.30
Predictors of amygdala activation during the processing of emotional stimuli: a meta-analysis of 385 PET and fMRI studies. Brain Res Rev (2007) 3.26
Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med (2007) 3.18
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2008) 3.15
Prevalence and predictors of mental incapacity in psychiatric in-patients. Br J Psychiatry (2005) 2.99
A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry (2004) 2.65
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62
Advancing paternal age and bipolar disorder. Arch Gen Psychiatry (2008) 2.56
Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. Am J Psychiatry (2014) 2.51
Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ (2013) 2.28
Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull (2005) 2.20
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned. Circulation (2002) 2.18
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Should the diagnostic boundaries of schizophrenia be expanded? Cogn Neuropsychiatry (2011) 2.07
Reliability of mental capacity assessments in psychiatric in-patients. Br J Psychiatry (2005) 2.07
Self-reflection and the brain: a theoretical review and meta-analysis of neuroimaging studies with implications for schizophrenia. Neurosci Biobehav Rev (2009) 2.05
Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2013) 1.96
A systematic review and quantitative appraisal of fMRI studies of verbal fluency: role of the left inferior frontal gyrus. Hum Brain Mapp (2006) 1.96
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. Schizophr Res (2006) 1.93
Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. Brain (2007) 1.91
Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci U S A (2010) 1.85
Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry (2012) 1.76
Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry (2012) 1.73
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry (2002) 1.72
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry (2009) 1.71
Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry (2004) 1.70
The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients. Int J Geriatr Psychiatry (2002) 1.67
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry (2012) 1.64
Decision-making capacity for treatment in psychiatric and medical in-patients: cross-sectional, comparative study. Br J Psychiatry (2013) 1.62
Neural systems underlying British Sign Language and audio-visual English processing in native users. Brain (2002) 1.60
Advanced paternal and grandpaternal age and schizophrenia: a three-generation perspective. Schizophr Res (2011) 1.57
The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry (2007) 1.57
Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology (2013) 1.56
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev (2014) 1.55
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry (2005) 1.55
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci (2005) 1.55
Time for a shift in focus in schizophrenia: from narrow phenotypes to broad endophenotypes. Br J Psychiatry (2005) 1.55
Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun (2005) 1.53
Processing speed deficits in schizophrenia: reexamining the evidence. Am J Psychiatry (2010) 1.52
The mental health of UK Gulf war veterans: phase 2 of a two phase cohort study. BMJ (2002) 1.50
Working alliance and its relationship to outcomes in a randomized controlled trial (RCT) of antipsychotic medication. BMC Psychiatry (2013) 1.50
Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets. Eur Neuropsychopharmacol (2005) 1.49
Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase. Am J Psychiatry (2011) 1.48
Heritability of brain volume, surface area and shape: an MRI study in an extended pedigree of baboons. Hum Brain Mapp (2007) 1.47
Chronic fatigue syndrome. BMJ (2010) 1.46
Belief models in first episode schizophrenia in South India. Soc Psychiatry Psychiatr Epidemiol (2007) 1.46
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res (2010) 1.43
A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods. Int J Circumpolar Health (2005) 1.43
Paternal age and intelligence: implications for age-related genomic changes in male germ cells. Psychiatr Genet (2005) 1.42
Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am J Psychiatry (2004) 1.42
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2002) 1.41
Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. Menopause (2002) 1.41
Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther (2011) 1.41
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry (2004) 1.41
Galantamine for the treatment of cognitive impairments in people with schizophrenia. Am J Psychiatry (2007) 1.39
Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr Bull (2006) 1.39
The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res (2013) 1.38
Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness. Br J Psychiatry (2005) 1.38
Low levels of circulating inflammatory cytokines--do they affect human brain functions? Brain Behav Immun (2002) 1.38
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophr Bull (2008) 1.38
Preterm birth and psychiatric disorders in young adult life. Arch Gen Psychiatry (2012) 1.38
Visual perceptual and working memory impairments in schizophrenia. Arch Gen Psychiatry (2002) 1.36
Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Arch Gen Psychiatry (2012) 1.35
Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation (2005) 1.34
Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry (2005) 1.34
Fronto-limbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Psychiatry Res (2007) 1.34
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr Psychiatry (2005) 1.34
Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog Lipid Res (2012) 1.33
Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord (2011) 1.33
Decrease in suicide rates after a change of policy reducing access to firearms in adolescents: a naturalistic epidemiological study. Suicide Life Threat Behav (2010) 1.33
Identifying socio-demographic and socioeconomic determinants of health inequalities in a diverse London community: the South East London Community Health (SELCoH) study. BMC Public Health (2011) 1.32
Validation of the modified telephone interview for cognitive status (TICS-m) in Hebrew. Int J Geriatr Psychiatry (2003) 1.31
Neural response to specific components of fearful faces in healthy and schizophrenic adults. Neuroimage (2009) 1.30
C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation (2005) 1.29
NMII forms a contractile transcellular sarcomeric network to regulate apical cell junctions and tissue geometry. Curr Biol (2013) 1.29